{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:24:22Z","timestamp":1792664662850,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jaad.2021.03.092","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T08:07:51Z","timestamp":1617782871000},"page":"46-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":690,"title":["Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases"],"prefix":"10.1016","volume":"85","author":[{"given":"Devon E.","family":"McMahon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Amerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Rosenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules B.","family":"Lipoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danna","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seemal R.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars E.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry W.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce H.","family":"Thiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Hruza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly G.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindy P.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther E.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.jaad.2021.03.092_bib1","first-page":"2603","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"383","author":"Baden","year":"2020","journal-title":"N Engl J Med"},{"issue":"27","key":"10.1016\/j.jaad.2021.03.092_bib2","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jaad.2021.03.092_bib3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaad.2020.05.109","article-title":"Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries","volume":"83","author":"Freeman","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.03.092_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaci.2012.04.003","article-title":"Adverse reactions to vaccines practice parameter 2012 update","volume":"130","author":"Kelso","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.jaad.2021.03.092_bib5","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/jama.2021.1967","article-title":"Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US-December 14, 2020-January 18, 2021","volume":"325","author":"Shimabukuro","year":"2021","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jaad.2021.03.092_bib6","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jaip.2020.12.047","article-title":"mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach","volume":"9","author":"Banerji","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"13","key":"10.1016\/j.jaad.2021.03.092_bib7","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMc2102131","article-title":"Delayed large local reactions to mRNA-1273 vaccine against SARS-CoV-2","volume":"384","author":"Blumenthal","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jaad.2021.03.092_bib8","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jaad.2020.06.1016","article-title":"The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries","volume":"83","author":"Freeman","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.03.092_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bjd.19163","article-title":"Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases","volume":"183","author":"Galvan Casas","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2021.03.092_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.19833","article-title":"SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19","author":"Welsh","year":"2021","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.03.092_bib11","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bjd.19327","article-title":"SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultraestructural study of 7 paediatric cases","volume":"183","author":"Colmenero","year":"2020","journal-title":"Br J Dermatol"},{"issue":"21","key":"10.1016\/j.jaad.2021.03.092_bib12","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1073\/pnas.86.21.8289","article-title":"H-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen response element","volume":"86","author":"Hamada","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jaad.2021.03.092_bib13","first-page":"111","article-title":"Erythromelalgia following influenza vaccine in a child","volume":"15","author":"Confino","year":"1997","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.03.092_bib14","first-page":"233","article-title":"First case of erythermalgia related to hepatitis B vaccination","volume":"26","author":"Rabaud","year":"1999","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.03.092_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijwd.2021.01.007","article-title":"The art of prevention: COVID-19 vaccine preparedness for the dermatologist","volume":"7","author":"Rice","year":"2021","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.jaad.2021.03.092_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2147\/CCID.S198081","article-title":"Delayed hypersensitivity reaction to hyaluronic acid dermal filler following influenza-like illness","volume":"12","author":"Turkmani","year":"2019","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.03.092_bib17","first-page":"53","article-title":"COVID-19\/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment","volume":"30","author":"Munavalli","year":"2021","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"10.1016\/j.jaad.2021.03.092_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.det.2011.08.002","article-title":"Dermatologic health disparities","volume":"30","author":"Buster","year":"2012","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2021.03.092_bib24","doi-asserted-by":"crossref","first-page":"n211","DOI":"10.1136\/bmj.n211","article-title":"How to vaccinate the world against covid-19","volume":"372","author":"Baraniuk","year":"2021","journal-title":"BMJ"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221006587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221006587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T23:26:08Z","timestamp":1724801168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962221006587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0190962221006587"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2021.03.092","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2021.03.092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}